Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Transfusion|March 13, 2015
Resolving the daratumumab interference with blood compatibility testingClaudia I Chapuy, Rachel T Nicholson, Maria D Aguad, et al.
Nature|November 25, 2011
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomasShanshan Duan, Lukas Cermak, Julia K Pagan, et al.
Blood|March 31, 2017
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphomaLakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2016
NLRC5/MHC class I transactivator is a target for immune evasion in cancerSayuri Yoshihama, Jason Roszik, Isaac Downs, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2011
Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3Thiha Aung, Bjoern Chapuy, Daniel Vogel, et al.
British Journal of Haematology|February 26, 2013
Tyrosinekinase inhibition facilitates cooperation of transcription factor SALL4 and ABC transporter A3 towards intrinsic CML cell drug resistanceTimo Hupfeld, Bjoern Chapuy, Verena Schrader, et al.
Blood|October 17, 2018
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCLKamil Bojarczuk, Kirsty Wienand, Jeremy A Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2015
Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and PixantroneRaphael Koch, Thiha Aung, Daniel Vogel, et al.
Plos One|April 19, 2012
Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomasMichael J Kluk, Bjoern Chapuy, Papiya Sinha, et al.
Pageof 7